|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
4581651 |
003 |
ICU |
005 |
20031021001500.0 |
008 |
010614s2001 nyu b 101 0 eng |
010 |
|
|
|a 2001041362
|
015 |
|
|
|a GBA2-02758
|
016 |
7 |
|
|a 101120544
|2 DNLM
|
020 |
|
|
|a 0306466376
|
035 |
|
|
|a (OCoLC)47177738
|
040 |
|
|
|a NLM
|c NLM
|d UKM
|d KKS
|d TKN
|d AGL
|d OCoLC
|d OrLoB-B
|
042 |
|
|
|a pcc
|
049 |
|
|
|a CGUA
|
060 |
1 |
0 |
|a WK 835
|b D53347 2001
|
070 |
0 |
|
|a QP901
|b .A33 v. 498
|
072 |
|
0 |
|a X380
|
082 |
0 |
4 |
|a 616.462
|2 21
|
090 |
|
|
|a RC700
|b .D5D525 2001
|
245 |
0 |
0 |
|a Diabetes and cardiovascular disease :
|b etiology, treatment, and outcomes /
|c edited by Aubie Angel ... [et al.].
|
260 |
|
|
|a New York :
|b Kluwer,
|c c2001.
|
300 |
|
|
|a xi, 415 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Advances in experimental medicine and biology.
|v 498
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Epidemiology and Genetic Determinants of Diabetes Mellitus --
|g 1.
|t Type 2 Diabetes in Youth: A New Epidemic /
|r H. Dean --
|g 2.
|t Undiagnosed Diabetes: Burden and Significance in the Canadian Population /
|r T. K. Young --
|g 3.
|t Genes, Environment and Diabetes in Canadian Aboriginal Communities /
|r R. A. Hegele --
|g 4.
|t Diabetes in Sub-Saharan Africa /
|r T. J. Aspray and N. Unwin --
|g 5.
|t Coronary Heart Disease and Risk Factors in Asian Indians /
|r M. Chandalia and P. C. Deedwania --
|t Metabolic Risk Factors in Diabetes and Cardiovascular Disease --
|g 6.
|t The Plasma Glucose Level - A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People /
|r H. C. Gerstein --
|g 7.
|t Modified Lipoproteins and Cardiovascular Risk /
|r W. Aldahi and J. Frohlich --
|g 8.
|t Advances in Lipid-Lowering Therapy in Atherosclerosis /
|r J. Davignon --
|g 9.
|t Homocysteine as a Risk Factor in Cardiovascular Disease /
|r D. E. C. Cole --
|g 10.
|t Endothelial Integrity and Repair /
|r T. J. Lee, S. Noria and J. Lee /
|r [et al.] --
|g 11.
|t Molecular Mechanisms of Endothelial Dysfunction in the Diabetic Heart /
|r P. Rosen, X. Du and G. Z. Sui --
|g 12.
|t A Study of Vascular Wound Healing in a Rabbit Model of Type I Diabetes /
|r N. K. Schiller, D. L. Akers and B. Burke /
|r [et al.] --
|g 13.
|t Endothelins in the Microvasculature and Heart in Diabetes /
|r S. Chakrabarti, S. Chen and T. Evans /
|r [et al.] --
|g 14.
|t Diabetes and Endothelial Function: Implications for Coronary Angioplasty /
|r T. J. Anderson --
|t Hypertension and Diabetes Mellitus --
|g 15.
|t The Effect of Hypertension in Diabetes /
|r E. D. Burgess --
|g 16.
|t The Diabetic Hypertensive (or Hypertensive Diabetic) - A Compelling Need to Optimize Blood Pressure /
|r S. G. Carruthers --
|g 17.
|t Left Ventricular Diastolic Dysfunction in Diabetic or Hypertensive Subjects: Role of Collagen Alterations /
|r T. J. Regan, G. N. Jyothirmayi and C. Laham /
|r [et al.] --
|g 18.
|t Alterations in the Vascular Actions of Insulin in the Pathogenesis of Insulin Resistance and Hypertension /
|r S. Verma and J. H. McNeill --
|g 19.
|t Cardiac Hypertrophy in Diabetes Patients with the without Hypertension: Effects of Troglitazone, a Novel Antidiabetic Drug, on Diastolic Function /
|r N. Makino, H. Hirayama and H. Yonemochi /
|r [et al.] --
|g 20.
|t Cost and Benefits of Blood Pressure Monitoring and Control /
|r A. Chockalingam and N. R. C. Campbell --
|t Cardiac Lipid Metabolism in Diabetes --
|g 21.
|t Malonyl COA Control of Fatty Acid Oxidation in the Diabetic Rat Heart /
|r G. D. Lopaschuk --
|g 22.
|t Alterations in 1,2-Diacylglycerol and Ceramides in Diabetic Rat Heart /
|r K. Okumura, K. Hayashi and K. Murase /
|r [et al.] --
|g 23.
|t Regulation of Myocardial Phospholipid N-Methylation by Insulin and Diabetes /
|r S. W. Schaffer and M. Mozaffari --
|g 24.
|t Reduction of Phosphatidylinositol-4,5-Bisphosphate Mass in Heart Sarcolemma during Diabetic Cardiomyopathy /
|r P. S. Tappia, S. Liu and Y. Tong /
|r [et al.] --
|g 25.
|t Tumor Necrosis Factor-[alpha], Sphingomyelinase and Ceramides Activate Tyrosine Kinase, p21Ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport and Insulin Resistance /
|r A. N. Hanna, J. Xu and D. N. Brindley --
|t Cardiac Function and Oxidative Stress in Diabetes --
|g 26.
|t Antioxidants, Free Radical Stress and Diabetes /
|r S. S. Rastogi and R. B. Singh --
|g 27.
|t Oxidative Stress and Functional Deficit in Diabetic Cardiomyopathy /
|r P. K. Singal, A. Bello-Klein and F. Farahmand /
|r [et al.] --
|g 28.
|t Ketosis and the Generation of Oxygen Radicals in Diabetes Mellitus /
|r S. K. Jain and K. Kannan --
|g 29.
|t Effect of Diabetes Mellitus on Hemodynamic and Cardiometabolic Correlates in Experimental Myocardial Infarction /
|r S. K. Gupta, D. S. Arya and U. Singh /
|r [et al.] --
|g 30.
|t Cardiac Function in Perfused Hearts from Diabetic Mice /
|r D. D. Belke, T. S. Larsen and D. L. Severson --
|g 31.
|t Mg[superscript 2+]-Dependent Atpase Activity in Cardiac Myofibrils from the Insulin-Resistant Jcr:La-Cp Rat /
|r T. Misra, J. C. Russell and T. A. Clark /
|r [et al.] --
|g 32.
|t Cyclic Nucleotide Phosphodiesterase Families in Intracellular Signaling and Diabetes /
|r A. Lugnier --
|g 33.
|t Alterations in G-Protein-Linked Signal Transduction in Cardiovascular Vascular Smooth Muscle in Diabetes /
|r M. B. Anand-Srivastava, R. Wang and Y. Y. Liu --
|t Glycemic Control and Improved Cardiovascular Function --
|g 34.
|t Mechanism of HDL Lowering in Insulin Resistant States /
|r G. F. Lewis, S. Rashid and K. D. Uffelman /
|r [et al.] --
|g 35.
|t Insulin Treatment Post Myocardial Infarction: The Digami Study /
|r K. Malmberg, A. Norhammar and L. Ryden --
|g 36.
|t Response to Ischemia and Endogenous Myocardial Protection in the Diabetic Heart /
|r T. Ravingerova, R. Stetka and M. Barancik /
|r [et al.] --
|g 37.
|t Type 2 Diabetes: Pharmacological Intervention in an Animal Model /
|r J. C. Russell --
|g 38.
|t The Diabetic Heart and Cardiac Glycosides /
|r M. Nagano --
|g 39.
|t Hyperglycemia-Induced Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells: Implications in the Pathogenesis of Vascular Dysfunction in Diabetes /
|r A. K. Srivastava --
|g 40.
|t Regulation of Myocardial and Skeletal Muscle NA,K-ATPase in Diabetes Mellitus in Humans and Animals /
|r H. Bundgaard and K. Kjeldsen --
|t Diabetes Management - A Multidisciplinary Approach --
|g 41.
|t Food Strategies for Diabetes and Heart Health /
|r K. Camelon --
|g 42.
|t The Atherosclerosis Reversal Clinic: The Way of the Future /
|r K. J. Kingsbury and J. Frolich --
|g 43.
|t Lipid Clinics/Cardiovascular Risk Reduction Clinics: Current State and Future Considerations /
|r J. Frohlich and K. Kingsbury --
|g 44.
|t Amputation Prevention and Rehabilitation in Diabetes /
|r J. M. Embil --
|g 45.
|t Laboratory Testing in Diabetes Mellitus /
|r M. Leroux --
|t Health Promotion in Preventing Diabetes and its Complications --
|g 46.
|t Diabetes and Cardiovascular Disease /
|r B. O'Connor --
|g 47.
|t Prevalence of Cardiovascular Risk Factors in Canadians with Diabetes Mellitus /
|r D. R. MacLean, M. R. Joffres and M. H. Tan /
|r [et al.] --
|g 48.
|t G7 Project Promoting Heart Health /
|r J. L. O'Loughlin, A. C. Edwards and S. Elliott /
|r [et al.] --
|g 49.
|t Canadian Heart Health Initiative: Research Review /
|r D. Harvey --
|t Health Policy and National Strategies in Diabetes --
|g 50.
|t Putting Policy into Action /
|r S. M. MacDonald --
|g 51.
|t National and International Strategies to Prevent Obesity and Diabetes /
|r B. A. Reeder --
|g 52.
|t The Diabetes Council of Canada (DCC): Coordinating National Diabetes Strategies /
|r N. W. Rodger --
|g 53.
|t The Federal Government and Diabetes: An Incremental Process /
|r W. P. Mickelson.
|
650 |
1 |
2 |
|a Diabetes Mellitus
|x complications
|v congresses.
|
650 |
2 |
2 |
|a Cardiovascular Diseases
|x etiology
|v Congresses.
|
650 |
|
0 |
|a Diabetic angiopathies.
|0 http://id.loc.gov/authorities/subjects/sh85037468
|
650 |
|
7 |
|a Diabetic angiopathies.
|2 fast
|0 http://id.worldcat.org/fast/fst00892225
|
700 |
1 |
|
|a Angel, Aubie.
|0 http://id.loc.gov/authorities/names/n83022136
|1 http://viaf.org/viaf/16137762
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i d6045c7f-5782-509a-b34a-2a689babadad
|s 7e0e3a01-e511-5ad1-acf4-dc996c379626
|
928 |
|
|
|t Library of Congress classification
|a RC700.D5D525 2001
|l JCL
|c JCL-Sci
|i 6415832
|
927 |
|
|
|t Library of Congress classification
|a RC700.D5D525 2001
|l JCL
|c JCL-Sci
|e CRERAR
|b 60097994
|i 7195721
|